石四药集团（02005.HK）今日盘中大涨5.28%，引起市场广泛关注。
根据联交所最新权益披露资料显示，公司执行董事兼主席兼行政总裁曲继广于前一交易日（3月31日）在场内增持了280万股公司股票，平均价格为3.1911港元，总投资额约为893.51万港元。此次增持后，曲继广的持股比例从38.81%上升至38.90%，持股数量达到1,149,226,000股。
分析人士指出，公司高管增持通常被视为对公司未来发展前景持积极态度的信号。曲继广作为公司的核心管理层，此次大手笔增持无疑向市场传递了强烈的信心，这可能是推动股价上涨的主要原因。投资者普遍认为，内部人士的买入行为往往基于对公司基本面的深入了解，因此此举可能预示着公司未来业绩向好。市场对这一利好消息反应积极，推动石四药集团股价在盘中出现显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.